For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
7
views
0
references
 Top references
cited by
171
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder cancer (NMIBC) treated with 1-3 yr of maintenance bacillus Calmette-Guérin (BCG).

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): Eur. Urol.
          Title: European urology
          Publisher: Elsevier BV
          ISSN (Electronic): 1873-7560
          ISSN (Print): 0302-2838
          Publication date (Electronic): Jan 2016
          Volume: 69
          Issue: 1
          Affiliations
          [1 ] EORTC Headquarters, Brussels, Belgium.
          [2 ] EORTC Headquarters, Brussels, Belgium. Electronic address: richard.sylvester@eortc.be.
          [3 ] Department of Surgical Sciences, Molinette Hospital, Torino, Italy.
          [4 ] Department of Urology, AUSL, Modena, Italy.
          [5 ] Department of Urology, OLVG, Amsterdam, The Netherlands.
          [6 ] Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands.
          [7 ] Department of Urology, Hospital Do Desterro, Lisbon, Portugal.
          [8 ] Department of Urology, Ghent University Hospital, Ghent, Belgium.
          [9 ] Department of Urology, St. James's University Hospital, Leeds, UK.
          [10 ] Department of Urology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
          [11 ] Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.
          [12 ] Department of Urology, Academic Medical Center, Amsterdam, The Netherlands.
          [13 ] Department of Urology, Marmara University School of Medicine, Istanbul, Turkey.
          [14 ] Department of Urology, Jeroen Bosch Ziekenhuis, s'-Hertogenbosch, The Netherlands.
          Article
          Publisher Item ID: S0302-2838(15)00556-4
          DOI: 10.1016/j.eururo.2015.06.045
          PubMed ID: 26210894
          SO-VID: 2756e674-943a-459d-8756-b345bdb0b28b
          History

          Keywords: Bacillus Calmette-Guérin,Non–muscle-invasive bladder cancer,Prognostic factors,Progression,Recurrence,Survival
          Data availability:
          Keywords: Bacillus Calmette-Guérin, Non–muscle-invasive bladder cancer, Prognostic factors, Progression, Recurrence, Survival

          Comments

          Comment on this article